제약용 건조 장비 시장 : 종류별, 운전 모드별, 재질별, 자동화 레벨별, 기술별, 용도별, 운영 규모별, 최종사용자별 - 세계 예측(2026-2032년)

The Pharmaceutical Drying Equipment Market was valued at USD 6.22 billion in 2025 and is projected to grow to USD 6.66 billion in 2026, with a CAGR of 9.11%, reaching USD 11.46 billion by 2032.

Comprehensive orientation on pharmaceutical drying equipment essentials highlighting process control, regulatory demands, energy performance, and supply chain resilience

Pharmaceutical drying equipment forms a foundational element of solid dosage and biologics manufacturing, where precise moisture control is integral to product stability, efficacy, and regulatory compliance. Modern drying systems are evaluated not merely for throughput but for their ability to deliver repeatable results across varied material classes while minimizing thermal and mechanical stress on sensitive actives. As process intensification and patient-centric formulations evolve, drying technologies must balance speed, gentleness, and validation readiness to meet stringent quality expectations.

Beyond the process itself, equipment selection is increasingly influenced by lifecycle considerations such as energy efficiency, cleanability, and the ability to integrate with digital control systems. Regulatory agencies continue to emphasize data integrity and process understanding, making drying systems that support process analytical technology and robust automation more attractive to manufacturers and contract development and manufacturing organizations. In turn, supply chain resilience and geopolitical developments are reshaping sourcing strategies for capital equipment, spare parts, and consumables, driving organizations to rethink procurement, maintenance, and installation timelines.

This executive summary synthesizes those drivers and their implications for leaders evaluating drying investments. It provides context on technological trends, segmentation-specific considerations, regional dynamics, and strategic levers that influence vendor selection and operational deployment. The aim is to equip decision-makers with a concise, evidence-based narrative that supports strategic planning without presuming specific forecasts or market sizing figures.

How convergence of digitalization, process intensification, advanced thermal technologies, and sustainability priorities is rapidly redefining drying equipment selection criteria

The landscape for pharmaceutical drying equipment is undergoing rapid transformation driven by converging forces: digitalization, process intensification, and material innovation. Advances in sensor technologies and control algorithms have elevated process understanding, enabling tighter moisture endpoints and reduced cycle variability. Consequently, process analytical technology, in-line monitoring, and model-based control are transitioning from pilot projects to routine features that enable faster validation and reduce batch rework.

Simultaneously, continuous manufacturing and modular production concepts are influencing dryer design and integration. Where batch systems once dominated, manufacturers are demanding equipment that can be adapted for continuous feeds, rapid changeovers, and scale-appropriate deployment. This shift is complemented by greater adoption of advanced drying modalities such as infrared-assisted and microwave-assisted techniques that can reduce residence times for specific chemistries while preserving critical quality attributes. At the same time, conventional heat-based and vibration-assisted systems remain indispensable for robust, well-understood processes, particularly where regulatory precedence favors established approaches.

Sustainability has emerged as a central consideration, with operators prioritizing energy-efficient heating systems, heat recovery, and lower greenhouse gas intensity. Consequently, equipment manufacturers are innovating across thermal sources and insulation strategies to reduce operating costs and improve environmental profiles. Finally, the global sourcing environment and regulatory scrutiny have increased emphasis on serviceability, spare parts availability, and validated installation support, prompting suppliers to expand after-sales networks and digital service offerings to minimize downtime and ensure compliance.

Practical analysis of how evolving tariff measures and cross-border trade frictions are reshaping procurement strategies, supplier footprints, and equipment sourcing risk profiles

The implementation of tariffs and trade policy adjustments in major importing jurisdictions introduces a complex set of operational and strategic considerations for pharmaceutical drying equipment stakeholders. Tariff-driven input cost increases can influence capital expenditure timing as purchasers weigh the relative cost of importing versus locally sourcing equipment or components. In response, many organizations reassess total landed cost, factoring in not only the tariff itself but also potential delays, customs processing, and the administrative overhead associated with cross-border procurement.

As costs and lead times fluctuate, several adaptation strategies become apparent. Some manufacturers accelerate procurement to secure supply before tariff changes take full effect, while others prioritize local assembly or the selection of suppliers with diversified manufacturing footprints to mitigate exposure. Contracting strategies evolve accordingly, with greater use of fixed-price contracts, hedging clauses, and extended warranties to contain financial risk. Tariff pressures also create incentives for greater standardization and modularity, enabling rapid local assembly and reducing the need to transport fully configured large-scale systems across high-tariff borders.

From a supplier perspective, tariffs can prompt reconfiguration of global supply chains, through either relocation of key production nodes or selective onshoring of critical components. This realignment can benefit buyers who require robust after-sales support and shorter service response times, but it also requires careful management of qualification and validation processes when components or subassemblies change source. Importantly, the cumulative effect of tariffs is not limited to capital equipment pricing; it propagates into spare parts procurement, validation services, and retrofitting projects, underscoring the need for procurement teams to adopt cross-functional evaluation criteria that include regulatory, operational, and logistical dimensions.

Segmentation-driven equipment selection insights explaining how type, operation mode, material characteristics, automation, and technology choices influence deployment and validation

Meaningful segmentation provides a structured lens to evaluate equipment choices and align them with process and organizational priorities. Based on type, drying systems bifurcate into moving beds and static beds; moving beds encompass technologies such as plate dryers, rotary drum dryers, screw conveyor dryers, spouted and fluid beds, and spray dryers, each offering different trade-offs between residence time distribution, heat transfer efficiency, and scale flexibility. Static beds include belt dryers, drum dryers, freeze dryers, tray dryers, and vacuum heaters, which are often preferred for processes demanding gentle handling, precise temperature control, or batch-level segregation.

Operation mode further refines selection criteria. Systems are categorized into directly heated dryers and indirectly heated dryers, and directly heated options span batch dryers and continuous dryers. The choice between direct and indirect heating affects contamination risk, thermal gradient control, and energy efficiency, while batch versus continuous operation determines suitability for small-batch R&D workstreams versus high-throughput production lines.

Material type is a primary determinant of drying strategy, with granular materials, pastelike materials, and solutions and suspensions each presenting distinct drying kinetics and scale-up challenges. Granular materials typically benefit from fluidization and mechanical agitation, pastelike matrices often require controlled low-shear drying environments, and solutions or suspensions favor atomization or freeze drying depending on the thermal sensitivity of the actives.

Automation level shapes operational consistency and data capture capabilities, ranging from fully automated systems to manual and semi-automated configurations. Fully automated solutions accelerate validation and reduce operator dependence but can increase initial capital and integration complexity, whereas semi-automated and manual systems may offer simpler qualification paths for small-scale or investigational production.

Technology choices split between advanced drying technologies and conventional drying technologies. Advanced methods include infrared-assisted and microwave-assisted drying, which can accelerate moisture removal for select chemistries and reduce thermal exposure, while conventional approaches include heat-based drying and vibration-assisted drying. Heat-based drying itself is further differentiated by thermal source-electric heating, gas heating, and steam heating-each with implications for energy efficiency, plant utilities, and emissions profiles.

Usage patterns guide equipment specifications with applications such as capsule drying, excipient conditioning, and granulate drying each driving distinct cycle requirements, containment needs, and cleanability standards. Scale of operation ranges from laboratory scale through pilot scale to production scale, and equipment must be both scalable and robust with predictable scale-up pathways to support process transfer. Finally, end-users including contract manufacturing organizations, pharmaceutical companies, and research institutes have different imperatives around throughput, flexibility, validation support, and cost structure, which informs procurement priorities, service level agreements, and the selection of OEMs or systems integrators.

Regional manufacturing, regulatory, and service ecosystem differences and how they shape equipment preferences, sourcing strategies, and validation support expectations

Regional dynamics play a decisive role in procurement logic, regulatory expectations, and service infrastructure for drying equipment. In the Americas, a strong presence of large-scale pharmaceutical manufacturing, integrated supply chains, and an emphasis on continuous improvement drives demand for high-capability dryers with advanced control features and robust after-sales support. The regulatory environment emphasizes data integrity and process understanding, encouraging adoption of in-line monitoring and validated automation to streamline inspection pathways and support life-cycle management.

Europe, Middle East & Africa present a heterogeneous landscape in which advanced regulatory frameworks coexist with emerging manufacturing hubs. In many European markets, energy efficiency mandates and environmental standards encourage equipment with superior thermal performance and lower emissions. Medical product quality regulations and national competent authority expectations favor established, well-documented technologies and suppliers that can provide localized validation support. Conversely, parts of the Middle East and Africa are investing in capacity-building initiatives that prioritize rapid installation, turnkey solutions, and training to accelerate local manufacturing capability.

Asia-Pacific remains a dynamic region with a broad spectrum of capabilities from global contract manufacturers to research-intensive institutions. Manufacturing density, cost considerations, and proximity to active pharmaceutical ingredient suppliers often make the region a focal point for both pilot and high-volume production. Local regulatory harmonization efforts and investments in advanced manufacturing infrastructure are driving uptake of modular and scalable drying solutions, while the geographic concentration of suppliers offers advantages in lead time and maintenance responsiveness. Across all regions, the availability of skilled technicians, spare parts logistics, and the maturity of the service ecosystem materially affect total cost of ownership and operational uptime.

Competitive supplier behaviors revealing how validation support, aftermarket services, and digital capabilities are becoming primary differentiators in equipment selection

Competitive dynamics among equipment suppliers are evolving from a focus on hardware specification toward integrated solution delivery that spans pre-sales support, validation assistance, and long-term service agreements. Leading suppliers differentiate through a combination of validated process libraries, modular designs that facilitate scale-up, and digital offerings that provide remote diagnostics, predictive maintenance, and improved spare-parts fulfillment. Partnerships between equipment OEMs and software providers are accelerating the deployment of condition-based servicing and remote calibration capabilities that reduce unplanned downtime and support compliance with data integrity requirements.

Key strategic behaviors include increased collaboration with contract development and manufacturing organizations to co-develop application-specific configurations, investment in regional service hubs to shorten response times, and expansion of financing options to lower capital barriers for high-specification systems. Some suppliers emphasize specialized niches-such as freeze drying for biologics or microwave-assisted drying for heat-sensitive APIs-while others pursue broad portfolios that cover both conventional and advanced technologies. Mergers, acquisitions, and distribution partnerships remain common methods to expand geographic reach and add complementary capabilities, with aftermarket revenue streams becoming a central profitability lever.

Practical and prioritized strategic recommendations for procuring, validating, and operating drying systems that reduce risk, accelerate validation, and align with sustainability goals

Industry leaders should adopt a proactive, multi-dimensional approach to equipment strategy that balances technical capability with commercial resilience. First, prioritize supplier relationships that demonstrate strong validation support, robust spare-parts ecosystems, and transparent documentation practices, as these attributes materially reduce qualification timelines and operational risk. Second, invest selectively in automation and process analytical technology to enhance reproducibility, reduce operator dependency, and accelerate regulatory acceptance of process controls.

Third, build procurement flexibility by qualifying multiple suppliers or selecting vendors with geographically diversified manufacturing footprints, which mitigates exposure to tariff shifts and logistical bottlenecks. Fourth, evaluate thermal and energy sources not only for capital cost but for lifecycle operating performance, considering heat recovery, utility compatibility, and decarbonization goals. Fifth, favor modular and scalable equipment designs that simplify scale-up from laboratory and pilot phases to production, thereby reducing technology transfer complexity and shortening development cycles.

Sixth, strengthen internal capabilities by investing in operator training, cross-functional process transfer teams, and in-house validation expertise to reduce reliance on external consultants. Seventh, pursue partnerships with academic and research institutions to pilot advanced drying modalities for challenging chemistries, enabling early familiarity and intellectual property understanding. Finally, incorporate tariff and regulatory scenario planning into capital investment frameworks so that procurement decisions are resilient to near-term policy shifts and long-term supply chain realignment.

Transparent explanation of the mixed-methods research approach that combines expert interviews, technical literature review, patent analysis, and iterative validation to ensure robust insights

The research underpinning this analysis integrates primary insights with systematic secondary review to ensure robust, triangulated conclusions. Primary inputs include structured interviews with equipment OEMs, process engineers in pharmaceutical manufacturers, quality assurance leads, and operations managers in contract manufacturing organizations. These dialogues focused on technology adoption barriers, validation challenges, maintenance practices, and procurement decision criteria to surface practitioner perspectives and real-world constraints.

Secondary research encompassed technical literature, regulatory guidance documents, patent filings, and publicly available product specifications to contextualize technological capabilities and compliance requirements. Comparative analysis of equipment design characteristics was complemented by cross-referencing supplier service models and documented case studies of process transfers. Findings were validated through iterative feedback from subject-matter experts and cross-checked against known industry practices to reduce bias and ensure practical relevance.

Limitations include variability in company-specific proprietary data and the evolving nature of regulatory guidance, which necessitate periodic updates to reflect new validation precedents and technological innovations. To mitigate these constraints, the methodology emphasizes transparency in source attribution, sensitivity to regional regulatory nuances, and the use of multiple corroborating evidence streams to support each core insight.

Concise synthesis of strategic imperatives and practical outcomes emphasizing integration of technology choice, validation readiness, serviceability, and supply chain resilience

In sum, pharmaceutical drying equipment decisions are increasingly multi-faceted, intertwining technical performance with regulatory readiness, energy considerations, and supply chain resilience. Technological advancements such as infrared and microwave-assisted drying, alongside improvements in automation and in-line analytics, are expanding the toolkit available to process developers and manufacturers; yet conventional heat-based and vibration-assisted systems remain indispensable for many established processes. Successful implementation depends not only on selecting an appropriate dryer type and thermal source but also on integrating validation-ready control systems, securing dependable after-sales support, and aligning procurement strategies with geopolitical realities.

Organizations that proactively align procurement, engineering, and quality teams will be better positioned to accelerate technology transfer, reduce validation timelines, and adapt to tariff-induced supply chain changes. Prioritizing modularity, serviceability, and energy performance while investing in operator competence and digital capabilities will deliver sustained operational resilience. Ultimately, a disciplined, segmentation-aware approach-grounded in rigorous vendor evaluation and scenario planning-will enable manufacturers and service providers to meet evolving product portfolios and regulatory expectations without sacrificing speed to market or product quality.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Drying Equipment Market, by Type

• 8.1. Moving Beds
  • 8.1.1. Plate Dryers
  • 8.1.2. Rotary Drum Dryer
  • 8.1.3. Screw Conveyor Dryer
  • 8.1.4. Spouted & Fluid Beds
  • 8.1.5. Spray Dryers
• 8.2. Static Beds
  • 8.2.1. Belt Dryers
  • 8.2.2. Drum Dryers
  • 8.2.3. Freeze Dryers
  • 8.2.4. Tray Dryers
  • 8.2.5. Vacuum Heaters

9. Pharmaceutical Drying Equipment Market, by Operation Mode

• 9.1. Directly Heated Dryers
  • 9.1.1. Batch Dryers
  • 9.1.2. Continuous Dryers
• 9.2. Indirectly Heated Dryers

10. Pharmaceutical Drying Equipment Market, by Material Type

• 10.1. Granular Material
• 10.2. Pastelike Material
• 10.3. Solutions & Suspensions

11. Pharmaceutical Drying Equipment Market, by Automation Level

• 11.1. Fully Automated
• 11.2. Manual
• 11.3. Semi-Automated

12. Pharmaceutical Drying Equipment Market, by Technology

• 12.1. Advanced Drying Technologies
  • 12.1.1. Infrared-Assisted Drying
  • 12.1.2. Microwave-Assisted Drying
• 12.2. Conventional Drying Technologies
  • 12.2.1. Heat-Based Drying
    • 12.2.1.1. Electric Heating
    • 12.2.1.2. Gas Heating
    • 12.2.1.3. Steam Heating
  • 12.2.2. Vibration-Assisted Drying

13. Pharmaceutical Drying Equipment Market, by Usage

• 13.1. Capsule
• 13.2. Excipients
• 13.3. Granulates

14. Pharmaceutical Drying Equipment Market, by Scale of Operation

• 14.1. Laboratory Scale
• 14.2. Pilot Scale
• 14.3. Production Scale

15. Pharmaceutical Drying Equipment Market, by End-User

• 15.1. Contract Manufacturing Organizations
• 15.2. Pharmaceutical Companies
• 15.3. Research Institutes

16. Pharmaceutical Drying Equipment Market, by Region

• 16.1. Americas
  • 16.1.1. North America
  • 16.1.2. Latin America
• 16.2. Europe, Middle East & Africa
  • 16.2.1. Europe
  • 16.2.2. Middle East
  • 16.2.3. Africa
• 16.3. Asia-Pacific

17. Pharmaceutical Drying Equipment Market, by Group

• 17.1. ASEAN
• 17.2. GCC
• 17.3. European Union
• 17.4. BRICS
• 17.5. G7
• 17.6. NATO

18. Pharmaceutical Drying Equipment Market, by Country

• 18.1. United States
• 18.2. Canada
• 18.3. Mexico
• 18.4. Brazil
• 18.5. United Kingdom
• 18.6. Germany
• 18.7. France
• 18.8. Russia
• 18.9. Italy
• 18.10. Spain
• 18.11. China
• 18.12. India
• 18.13. Japan
• 18.14. Australia
• 18.15. South Korea

19. United States Pharmaceutical Drying Equipment Market

20. China Pharmaceutical Drying Equipment Market

21. Competitive Landscape

• 21.1. Market Concentration Analysis, 2025
  • 21.1.1. Concentration Ratio (CR)
  • 21.1.2. Herfindahl Hirschman Index (HHI)
• 21.2. Recent Developments & Impact Analysis, 2025
• 21.3. Product Portfolio Analysis, 2025
• 21.4. Benchmarking Analysis, 2025
• 21.5. amixon GmbH
• 21.6. Andritz AG
• 21.7. Azbil Corporation
• 21.8. BEW Engineering Limited
• 21.9. Buchi Labortechnik AG
• 21.10. Dedert Corporation
• 21.11. European SprayDry Technologies
• 21.12. FREUND Corporation
• 21.13. G. Larsson Starch Technology AB
• 21.14. GEA Group AG
• 21.15. GEM Pharma
• 21.16. HEINKEL Process Technology GmbH -
• 21.17. Hosokawa Micron Corporation
• 21.18. Hovione Farmaciencia, S.A.
• 21.19. IMA Group
• 21.20. Lonza Group Ltd
• 21.21. MechaTech Systems Ltd.
• 21.22. MERIDION GmbH
• 21.23. Ohara Technologies
• 21.24. OPTIMA packaging group GmbH
• 21.25. SaintyCo
• 21.26. Saka Engineering Systems Pvt. Ltd. (India)
• 21.27. Shree Bhagwati Group
• 21.28. SP Industries, Inc.
• 21.29. SPX FLOW, Inc.
• 21.30. Syntegon Technology GmbH
• 21.31. Tsukishima Holdings Co., Ltd
• 21.32. Yamato Scientific co., ltd.
• 21.33. ZIRBUS technology GmbH